Centro Médico Teknon

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Obesity6 trials
• Ulcerative colitis6 trials
• Crohn's disease2 trials
• Obstructive sleep apnoea2 trials
• Aortic stenosis1 trial
• Coronary artery disease1 trial
• Heart failure1 trial

Phase

• Phase 36 trials
• Phase 22 trials
• Phase 42 trials
• Phase 11 trial

Status

• Completed6 trials
• Active, not recruiting5 trials
• Recruiting3 trials

Lead sponsor

• Eli Lilly and Company4 trials
• Amgen2 trials
• Abivax S.A.1 trial
• Alfasigma S.p.A.1 trial
• Biotronik SE & Co. KG1 trial
• and 5 more

Running trials

• Active, not recruiting

  Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

  NCT07225686· Phase 3· Amgen· Source

• Active, not recruiting

  Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

  NCT07226765· Phase 3· Amgen· Source

• Recruiting

  LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  NCT07186101· Phase 2· Eli Lilly and Company· Source

  Contact: Miquel Sans Cuffi (principal investigator)

• Recruiting

  Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  NCT06937099· Phase 3· Eli Lilly and Company· Source

  Contact: Miquel Sans Cuffi (principal investigator)

• Recruiting

  Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  NCT06937086· Phase 3· Eli Lilly and Company· Source

  Contact: Miquel Sans Cuffi (principal investigator)

• Active, not recruiting

  A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  NCT05869903· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

  NCT05177835· Phase 2· Abivax S.A.· Source

• Active, not recruiting

  Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices

  NCT03366545· Biotronik SE & Co. KG· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Ulcerative colitis2 recruiting
• Crohn's disease1 recruiting

Closed trials

• Completed

  A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

  NCT06582264· Phase 1· Microbiotica Ltd· Source

• Completed

  The Safety and Efficacy of Good Feeling Power® for IBD Patients

  NCT07766733· Good Feeling Products GmbH· Source

• Completed

  Procedure for Duodenal-Ileal Diversion for Patients With Weight Regain Following Sleeve Gastrectomy

  NCT05049824· GI Windows, Inc.· Source

• Completed

  Dapagliflozin After Transcatheter Aortic Valve Implantation

  NCT04696185· Phase 4· Spanish Society of Cardiology· Source

• Completed

  TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

  NCT03596385· Phase 4· Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III· Source

• Completed

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· Phase 3· Alfasigma S.p.A.· Source